Acalovschi I, Szilagy E, Fleşeru M, Schiop I
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1989 Sep-Oct;38(5):387-96.
The hemodynamic modifications during anesthesia induction with etomidat or thiopentalum, with and without pretreatment with fentanyl, were studied in 60 ASA I-II patients. The patients were randomly divided into six subgroups, as a function of the induction agent (etomidat, 0.15 mg/kg, or thiopentalum, 3 mg/kg) and of the pretreatment used (fentanyl, 5 micrograms/kg, or 0.9% 1 ml/kg saline solution). Systolic, diastolic ATs and pulse were followed and measured during induction and after tracheal intubation. During induction the presence or absence of the thoracic rigidity, after fentanyl administration, and also the appearance of myoclonias and of local pain after etomidat injection were noted. Measurement of hemodynamic constants showed, in the control subgroups unprotected by fentanyl, that AT and pulse frequency increase following laryngoscopy and intubation irrespective of the induction agent used. Association of thiopentalum with fentanyl influenced partially tachycardia and postintubation hypertension. Administration of 5 micrograms/kg fentanyl prevented the SAT and pulse modifications but not the DAT variation. Association of 10 micrograms/kg fentanyl ensured a complete protective effect versus the tracheal intubation but, it led, first, to a SAT decrease by intensification of the myocardial depressing effect of the barbiturate. On the other hand, use of fentanyl as induction adjuvant with etomidat ensured the blockage of the pressure response to intubation, with hemodynamic stability during anesthesia induction, irrespective of the dose of fentanyl injected. Thoracic rigidity and the side effects generated by etomidate were absent.
在60例ASA I-II级患者中,研究了依托咪酯或硫喷妥钠麻醉诱导期间,在使用和不使用芬太尼预处理的情况下的血流动力学改变。根据诱导药物(依托咪酯0.15mg/kg或硫喷妥钠3mg/kg)和预处理药物(芬太尼5μg/kg或0.9% 1ml/kg生理盐水溶液),将患者随机分为六个亚组。在诱导期间和气管插管后,监测并测量收缩压、舒张压、平均动脉压和脉搏。记录诱导期间给予芬太尼后是否出现胸壁强直,以及注射依托咪酯后是否出现肌阵挛和局部疼痛。血流动力学常数测量显示,在未用芬太尼保护的对照组亚组中,无论使用何种诱导药物,喉镜检查和插管后平均动脉压和脉搏频率都会增加。硫喷妥钠与芬太尼联合使用部分影响心动过速和插管后高血压。给予5μg/kg芬太尼可预防收缩压和脉搏变化,但不能预防舒张压变化。给予10μg/kg芬太尼可确保对气管插管有完全的保护作用,但首先会因巴比妥类药物心肌抑制作用增强导致收缩压下降。另一方面,使用芬太尼作为依托咪酯诱导的辅助药物可确保阻断插管时的压力反应,麻醉诱导期间血流动力学稳定,无论注射芬太尼的剂量如何。未出现胸壁强直和依托咪酯产生的副作用。